Visby Medical Stock

PCR-Based Medical Testing

Sign up today and learn more about Visby Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Visby Medical Stock

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.


Biomedical Advanced Research and Development Authority (BARDA)

Visby Medical

Artiman Ventures

ApplyBoard, Visby Medical

Valo Ventures

Visby Medical

J Ventures

Visby Medical

Funding History

December 2012$6.0M
January 2018$9.5M
April 2019$100M
February 2021$12.3M


Chief Executive Officer

Adam de la Zerda

Chief Financial Officer

Mark Ibison


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: